Q1 2024 Earnings Forecast for LENZ Therapeutics, Inc. (NASDAQ:LENZ) Issued
By Leerink Partnrs
Related Articles
-
El Pollo Loco Holdings, Inc. Forecasted to Post Q1 2024 Earnings of $0.13 Per Share (NASDAQ:LOCO)
El Pollo Loco Holdings, Inc. (NASDAQ:LOCO – Free Report) – Analysts at William Blair boosted their Q1 2024 earnings per share (EPS) estimates for shares of El Pollo Loco in a research note issued to investors on Wednesday, April 24th. William Blair analyst S. Zackfia now expects that the restaurant operator will post earnings per […]
-
Sage Therapeutics (NASDAQ:SAGE) Price Target Cut to $25.00 by Analysts at HC Wainwright
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price objective reduced by stock analysts at HC Wainwright from $28.00 to $25.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside […]
-
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 2.8% After Analyst Upgrade
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) rose 2.8% during mid-day trading on Thursday after Citigroup raised their price target on the stock from $88.00 to $89.00. Citigroup currently has a buy rating on the stock. CRISPR Therapeutics traded as high as $57.19 and last traded at $57.11. Approximately 273,490 shares changed […]